Potential pathogenic role of Mycobacterium avium subspecies paratuberculosis in Crohn's disease

Inflammatory Bowel Diseases

Volumn 14, Issue 12, 2008, Pages 1753-1755

  Shafran, Ira ^a   Burgunder, Patricia ^a  

^a Shafran Gastroenterology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; MACROLIDE; RIFABUTIN;

ANTIGEN DETECTION; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; IMMUNE RESPONSE; IN SITU HYBRIDIZATION; INFLAMMATION; LETTER; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT RESPONSE; MICROBIOLOGY; MYCOBACTERIUM PARATUBERCULOSIS; NOTE; PARATUBERCULOSIS; PATHOGENICITY; PATHOLOGY;

CROHN DISEASE; HUMANS; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS; PARATUBERCULOSIS;

EID: 59849088585     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20513     Document Type: Letter

References (8)

1. Domènech E. Inflammatory bowel disease: current therapeutic options. Digestion. 2006; 73(suppl 1):67-76.
2. Chamberlin W, Graham DY, Hulten K, et al. Mycobacterium avium subsp. paratuberculosis as one cause of Crohn's disease. Aliment Pharmacol Ther. 2001;15:337-346.
3. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and metaanalysis. Lancet Infect Dis. 2007;7:607-613.
4. Abubakar I, Myhill D, Aliyu SH, et al. Detection of Mycobacterium avium subspecies paratuberculosis from patients with Crohn's disease using nucleic acid-based techniques: a systematic review and meta-analysis. Inflamm Bowel Dis. 2008;14:401-410.
5. Schwartz D, Shafran I, Romero C, et al. Use of a short-term culture for identification of Mycobacterium avium subsp. paratuberculosis in tissue from Crohn's disease patients. Clin Microbiol Infect. 2000;6:303-307.
6. Greenstein RJ. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis. 2003;3:507-514.
7. Shafran I, Kugler L, El-Zaatari FA, et al. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis. 2002;34:22-28.
8. Inglis TJJ. Principia aetiologica: taking causality beyond Koch's postulates. J Med Microbiol. 2007;56:1419-1422.